← Back to catalogue
Research draft

osteosarcoma

vr.tr.osteosarcoma · XCT.STA

Let an agent explain osteosarcoma in general terms from oncology guidelines, describe symptoms, diagnosis, treatment and outcomes, distinguish it from other bone sarcomas and benign bone conditions, and route personal questions to clinicians.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain osteosarcoma in general terms from oncology guidelines, describe symptoms, diagnosis, treatment and outcomes, distinguish it from other bone sarcomas and benign bone conditions, and route personal questions to clinicians.

The most common primary malignant bone tumour, arising from bone-forming cells, most often in the long bones around the knee and shoulder in adolescents and young adults as pediatric osteosarcoma and with a second peak in older adults, presenting as localized or metastatic disease, and grouped with rarer bone sarcomas such as fibrosarcoma of bone, malignant fibrous histiocytoma of bone and vascular sarcomas; osteosarcoma is treated with chemotherapy and surgery, and survival for localized disease has improved to about 60 to 70 percent.

What it is for: Not applicable; a cancer.

It can be explain the disease; relay symptoms and diagnosis; relay treatment and outcomes; route personal questions.

Distinguishing features

Bone-forming tumour

Adolescent peak

Chemotherapy and surgery

Metastasis to lungs

What it looks like

Not a visible object; a bone tumour seen on imaging.

Physical character

incidence: about 3-4 per million per year

five-year survival, localized: about 60-70 percent

peak age: 10-20 years

How it is recognised

Malignant bone-forming tumour

Localized and metastatic osteosarcoma; pediatric and adult forms; related bone sarcomas

Ewing sarcoma and chondrosarcoma are other bone sarcomas; bone metastases from other cancers differ

Related models

is a kind of - in registry terms

bone sarcoma

is a kind of - in registry terms

osteogenic neoplasm

is a kind of - in registry terms, as a paediatric cancer

paediatric oncology

is treated by - and limb-sparing surgery

chemotherapy

In practice

Families and kinds

conventional high-grade osteosarcoma

localized osteosarcoma

metastatic osteosarcoma

pediatric osteosarcoma

secondary osteosarcoma in Paget disease or after radiation

related bone sarcomas such as fibrosarcoma of bone, malignant fibrous histiocytoma of bone and angiosarcoma of bone

Identifiers

ICD-11 2B51 osteosarcoma of bone and articular cartilage

MeSH D012516 osteosarcoma

Standards and regulation

ESMO and NCCN bone sarcoma guidelines

Paediatric oncology protocols such as EURAMOS

Cancer registration standards

Failure modes and hazards

Delayed diagnosis mistaken for growing pains or injury

Agents giving personal medical advice

Confusing with other bone tumours

Also called

metastatic osteosarcomafibrosarcoma of bonepediatric osteosarcomabone angioendothelial sarcomamalignant fibrous histiocytoma of bonelocalized osteosarcomaextraosseous osteosarcomamultifocal osteogenic sarcomabone leiomyosarcomachondroblastic osteosarcomabone osteosarcomametachronous osteosarcoma of the boneliposarcoma of bonerecurrent osteosarcomaparosteal osteosarcomalow grade central osteosarcomaOSLAM syndrome

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Help Getting help first.

Safety.

Signs

Warning signs.

Signs

Signs.

  1. What signs, such as persistent bone pain, swelling or a fracture without cause, need prompt assessment? action
  2. Is the user describing such symptoms, which need a clinician promptly? boundary

Care

Specialist care.

Care

Care.

  1. How is osteosarcoma diagnosed and staged by specialist sarcoma teams, in general terms? provenance
  2. Is the user asking about their own diagnosis, which needs their oncology team? boundary
Understand The cancer.

Clinical.

Disease

Disease and types.

Disease

Disease.

  1. What is osteosarcoma, who is affected, and what types exist? definition
  2. Is the question about osteosarcoma or another bone tumour? boundary

Causes

Causes and risk.

Causes

Causes.

  1. What is known about causes and risk factors, such as growth, genetics, Paget disease and radiation? provenance
  2. Which entry fits the specific risk factor? action
Treat Treatment.

Clinical.

Treatment

Treatment.

Treatment

Treatment.

  1. What treatments do guidelines recommend, from chemotherapy to limb-sparing surgery, in general terms? provenance
  2. Which references are standard? provenance

Outcomes

Outcomes and follow-up.

Outcomes

Outcomes.

  1. What outcomes are seen for localized and metastatic disease, and what follow-up and rehabilitation exist? provenance
  2. Which sources are cited? provenance
Context Research and support.

Context.

Research

Research.

Research

Research.

  1. What research addresses new therapies and biology, with findings attributed? provenance
  2. Which entry fits sarcoma research? action

Support

Support.

Support

Support.

  1. What organisations support patients and families? provenance
  2. Which entry fits the specific organisation? action

What the second pass must settle

  • Should bone sarcoma be the primary linked entry?
  • How should guidelines be linked?
  • The registry entry has merged aliases naming distinct rare sarcomas; should they be split off?